WASHINGTON CAPITAL MANAGEMENT, INC

Position in BMRN — Biomarin Pharmaceutical Inc

CIK 928566 SEATTLE, WA

Position in BMRN

as of Jun 30, 2026 · filed Jul 21, 2026 Compact

Position Value

$580,783

+$7,410 QoQ

Shares Held

10,150

0.0% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.58%

of 13F equity value

Holder Rank

#323

of 561 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

WASHINGTON CAPITAL MANAGEMENT, INC holds $580,783 across 1 Biotechnology name. BMRN ranks #1 (100.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)	Open
1	BMRN	Biomarin Pharmaceutical Inc This page	10,150	$580,783

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$580,783	10,150	0.0%	Shares	Sole	2026-07-21
2026-03-31	$573,373	10,150	+136.0%	Shares	Sole	2026-04-27
2025-12-31	$255,549	4,300	-33.8%	Shares	Sole	2026-01-29
2024-06-30	$535,145	6,500	0.0%	Shares	Sole	2024-07-19
2024-03-31	$567,710	6,500	0.0%	Shares	Sole	2024-04-12
2023-12-31	$626,730	6,500	0.0%	Shares	Sole	2024-01-19
2023-09-30	$575,120	6,500	-20.7%	Shares	Sole	2023-10-26
2021-06-30	$684,208	8,200	0.0%	Shares	Sole	2021-08-11
2021-03-31	$619,182	8,200	0.0%	Shares	Sole	2021-05-04
2020-12-31	$719,058	8,200	0.0%	Shares	Sole	2021-02-05
2020-09-30	$623,856	8,200	+26.2%	Shares	Sole	2020-11-05
2020-06-30	$801,710	6,500	0.0%	Shares	Sole	2020-08-04
2020-03-31	$549,250	6,500	—	Shares	Sole	2020-05-06
No filing history on record for this holder in this stock.